Mid-cap Consumer Cyclical company Bath & Body Works has moved -2.2% so far today on a volume of 3,013,561, compared to its average of 2,853,987. In contrast, the S&P 500 index moved 0.0%.
Bath & Body Works trades -23.36% away from its average analyst target price of $52.26 per share. The 18 analysts following the stock have set target prices ranging from $42.0 to $65.0, and on average have given Bath & Body Works a rating of buy.
Anyone interested in buying BBWI should be aware of the facts below:
-
Bath & Body Works has moved 11.3% over the last year, and the S&P 500 logged a change of 25.0%
-
Based on its trailing earnings per share of 3.87, Bath & Body Works has a trailing 12 month Price to Earnings (P/E) ratio of 10.3 while the S&P 500 average is 27.65
-
BBWI has a forward P/E ratio of 10.7 based on its forward 12 month price to earnings (EPS) of $3.75 per share
-
The company has a price to earnings growth (PEG) ratio of 2.48 — a number near or below 1 signifying that Bath & Body Works is fairly valued compared to its estimated growth potential
-
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.
-
Based in Columbus, the company has 8,981 full time employees and a market cap of $8.94 Billion. Bath & Body Works currently returns an annual dividend yield of 2.0%.